Current Respiratory Medicine Reviews

Author(s): Mukesh Masand*, Pramod Kumar Sharma, Vishal M. Balaramnavar and Deepti Mathpal

DOI: 10.2174/1573398X18666220503184459

DownloadDownload PDF Flyer Cite As
Tuberculosis: Current Progress in Drug Targets, Potential Drugs and Therapeutic Impact

Page: [165 - 170] Pages: 6

  • * (Excluding Mailing and Handling)

Abstract

The World Health Organization (WHO) considers tuberculosis to be the most dangerous chronic communicable disease in the world, infecting two billion people or one-third of the world’s population. Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a leading cause of mortality worldwide into the 21st century. Tuberculosis is second only to AIDS among other infectious diseases causing deaths worldwide. The emergence of AIDS, multidrug-resistant TB (MDRTB), extensively drug-resistant tuberculosis (XDR-TB), the decline of socioeconomic standards, and a reduced emphasis on tuberculosis control programmers contribute to the disease’s resurgence in industrialized countries.

Keywords: Phthisis, white plague, drug resistance, multidrug-resistant TB (MDR-TB), extensively drug-resistant tuberculosis (XDR-TB), fluoroquinolones (FQ), topoisomerases, phototoxicity.